2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Aurion Biotech: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1) AURN001, Corneal Endothelial Cells, Y27632 - Corneal Edema, Corneal Endothelial Dysfunction | Phase 1 / Phase 2 | Completed | Aurion Biotech | 97 | 2023-10-18 | 2025-12-17 |
| A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction HCEC-1 - Corneal Edema | Phase 1 | Completed | Aurion Biotech | 22 | 2022-03-24 | 2024-08-19 |
Corneal Edema (2)
Y 27632 (1)
Canada (1) · El Salvador (1) · United States (1)